CompletedPhase 2NCT00436618

Everolimus in Treating Patients With Lymphoma That Has Relapsed or Not Responded to Previous Treatment

Studying Acute lymphoblastic leukemia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Mayo Clinic
Principal Investigator
Thomas E. Witzig, MD
Mayo Clinic
Intervention
Everolimus(drug)
Enrollment
277 enrolled
Eligibility
18-120 years · All sexes
Timeline
20052019

Study locations (3)

Collaborators

National Cancer Institute (NCI)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00436618 on ClinicalTrials.gov

Other trials for Acute lymphoblastic leukemia

Additional recruiting or active studies for the same condition.

See all trials for Acute lymphoblastic leukemia

← Back to all trials